GO:0045339 farnesyl diphosphate catabolic process: Isoprenoid Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045339 (farnesyl diphosphate catabolic process) describes the biochemical reactions that break down farnesyl diphosphate (FPP), a central isoprenoid intermediate [1,3].
• FPP catabolism is essential for balancing the mevalonate pathway, which produces cholesterol, prenylated proteins, and other isoprenoids [1,6].
• Dedicated farnesyl diphosphate synthases and catabolic enzymes prevent the accumulation of toxic intermediates and support metabolic flexibility [4,5].
• Dysregulation of FPP catabolism is linked to vascular inflammation, oocyte aging, and microbial virulence [1,3,5].
• Key genes include FDPS, GGPS1, and prenyltransferases such as PGGT1B and FNTA, which consume FPP in prenylation reactions [1,2].
• CRISPR knockout, point mutation, and overexpression models enable precise dissection of FPP catabolic pathways in human cells and pathogens [1,5].
Description
Farnesyl diphosphate (FPP) is a central metabolite in the mevalonate pathway, serving as a precursor for sterols, dolichols, ubiquinones, and prenylated proteins [1,6]. The catabolic process of FPP, annotated as GO:0045339, encompasses the enzymatic reactions that degrade FPP into downstream products, thereby controlling its cellular levels and preventing toxic accumulation [3,4]. This process is critical for maintaining metabolic homeostasis and is conserved from bacteria to humans [5,8]. Research has shown that FPP catabolism intersects with diverse physiological and pathological states. For instance, in aged oocytes, mevalonate metabolites including FPP support prenylation of small GTPases, and their catabolism influences oocyte quality. In Behçet's disease, TNF inhibitors modulate a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils, highlighting the clinical relevance of FPP breakdown. In plants, dedicated FPP synthases circumvent growth-defense tradeoffs by channeling FPP into specialized metabolites. Understanding GO:0045339 is therefore essential for researchers studying isoprenoid metabolism, protein prenylation, and related diseases. This article provides a comprehensive overview of the definition, mechanisms, key genes, and experimental models for investigating FPP catabolism.
farnesyl diphosphate catabolic process At A Glance
| GO ID | GO:0045339 |
|---|---|
| GO term | farnesyl diphosphate catabolic process |
| Ontology | biological_process |
| Synonym | farnesyl diphosphate breakdown, farnesyl diphosphate catabolism, farnesyl diphosphate degradation |
| Major function | Breakdown of farnesyl diphosphate to maintain metabolic balance and supply downstream isoprenoids |
| Related metabolites | Farnesyl diphosphate, geranylgeranyl diphosphate, sterols, prenylated proteins |
| Key enzymes | Farnesyl diphosphate synthase (FDPS), geranylgeranyl diphosphate synthase (GGPS1), prenyltransferases |
| Cellular location | Cytosol, endoplasmic reticulum, peroxisomes, mitochondria |
| Pathological relevance | Vascular inflammation, oocyte aging, microbial virulence [1,3,5] |
What Is GO:0045339?
GO:0045339, farnesyl diphosphate catabolic process, is defined as the chemical reactions and pathways resulting in the breakdown of farnesyl diphosphate (FPP). This includes enzymatic steps that convert FPP into downstream isoprenoids such as geranylgeranyl diphosphate, sterols, or other catabolic products, as well as the prenylation reactions that consume FPP [1,2,6]. The term is a biological process and is synonymous with farnesyl diphosphate breakdown, catabolism, and degradation.
Why Is farnesyl diphosphate catabolic process Important in Cell Biology?
FPP catabolism is vital because FPP sits at the crossroads of multiple essential biosynthetic pathways. Its breakdown ensures a balanced flux toward cholesterol, prenylated proteins, and other isoprenoids, while preventing the accumulation of intermediates that can be toxic or disrupt signaling [1,6]. Dysregulation of FPP catabolism has been implicated in aging, inflammatory diseases, and infections, making it a target for therapeutic intervention [1,3,5].
• Maintains cellular homeostasis by preventing toxic accumulation of FPP and its derivatives [3,4].
• Supplies precursors for protein prenylation, which is critical for small GTPase function [1,2].
• Regulates cholesterol biosynthesis and other mevalonate pathway outputs.
• Influences oocyte quality and reproductive aging through prenylation of small GTPases.
• Modulates inflammatory signaling in neutrophils, with implications for vasculitis.
• Supports metabolic versatility in pathogens like Staphylococcus aureus.
• Plays a role in plant growth-defense tradeoffs by channeling FPP into sesquiterpenes [4,7].
• Is a target of bisphosphonates in Toxoplasma gondii, affecting parasite survival.
• Provides a metabolic checkpoint for cell proliferation and differentiation [1,6].
• Offers opportunities for CRISPR-based functional studies and drug discovery [1,5].
What Happens During farnesyl diphosphate catabolic process?
FPP Synthesis and Availability
In simple terms: FPP is first made by combining smaller molecules, and its levels are tightly controlled.
Farnesyl diphosphate is synthesized by farnesyl diphosphate synthase (FDPS) through the sequential condensation of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). In plants, dedicated FDPS isoforms channel FPP into specialized metabolic pathways, avoiding tradeoffs between growth and defense. In bacteria like Staphylococcus aureus, a redundant isoprenoid biosynthetic pathway supports FPP production for metabolic versatility.
Enzymatic Breakdown of FPP
In simple terms: Enzymes cut FPP into smaller pieces or use it to modify proteins.
The catabolic process of FPP involves its conversion to geranylgeranyl diphosphate (GGPP) by geranylgeranyl diphosphate synthase (GGPS1), or its use as a substrate for prenyltransferases such as farnesyltransferase (FTase) and geranylgeranyltransferase (GGTase) [1,2]. These reactions consume FPP and attach farnesyl or geranylgeranyl groups to target proteins, a process known as prenylation. In fungi, cyclo-farnesyl diphosphate-dependent prenylation has been described, expanding the repertoire of FPP catabolic routes.
Prenylation of Small GTPases
In simple terms: FPP is used to tag proteins so they can attach to cell membranes.
Prenylation of small GTPases such as Rho, Rac, and Rab is a major catabolic fate of FPP. This modification is essential for their membrane localization and signaling functions. In aged oocytes, mevalonate metabolites including FPP boost quality through prenylation of small GTPases, and inhibition of this process impairs oocyte maturation. Similarly, in Behçet's disease, TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils, linking FPP catabolism to inflammatory responses.
Regulation of FPP Catabolism
In simple terms: The breakdown of FPP is turned up or down based on the cell's needs.
FPP catabolism is regulated by feedback mechanisms that sense sterol and isoprenoid levels. For example, statins inhibit HMG-CoA reductase, reducing FPP synthesis and indirectly affecting its catabolism. In Toxoplasma gondii, the bifunctional FDPS/GGPPS enzyme is a target of bisphosphonates, which disrupt FPP catabolism and parasite survival. Additionally, in tomato fruit, plastidial engineering with coupled FPP pool reconstitution enhances sesquiterpene biosynthesis, demonstrating that FPP catabolism can be redirected for metabolic engineering.
Key Genes Involved in GO:0045339 farnesyl diphosphate catabolic process
The following genes and proteins are central to farnesyl diphosphate catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FDPS | Synthesizes FPP from IPP and DMAPP | Target of bisphosphonates; knockout reduces FPP levels [6,8] |
| GGPS1 | Converts FPP to GGPP | Regulates prenylation of Rab GTPases; knockout affects membrane trafficking |
| FNTA | Farnesyltransferase alpha subunit | Essential for prenylation of Ras and Rho; knockout impairs signaling |
| FNTB | Farnesyltransferase beta subunit | Catalytic subunit of FTase; point mutations alter substrate specificity |
| PGGT1B | Geranylgeranyltransferase type I beta subunit | Prenylates Rho GTPases; knockout affects cytoskeleton |
| RABGGTA | Rab geranylgeranyltransferase alpha subunit | Prenylates Rab proteins; mutations linked to disease |
| RABGGTB | Rab geranylgeranyltransferase beta subunit | Catalytic subunit for Rab prenylation |
| HMGCR | Rate-limiting enzyme in mevalonate pathway | Statin target; affects FPP synthesis and catabolism |
| SQLE | Converts squalene to cholesterol | Downstream of FPP; knockout alters sterol synthesis |
| CYP51A1 | Sterol 14-alpha demethylase | Involved in cholesterol biosynthesis; FPP catabolism crosstalk |
| TRPM2 | Calcium channel | Mediates mevalonate metabolite signaling in neutrophils |
| RHO | Small GTPase | Prenylation target of FPP; regulates actin cytoskeleton |
| RAC1 | Small GTPase | Prenylation target; involved in NADPH oxidase activation |
| CDC42 | Small GTPase | Prenylation target; regulates cell polarity |
| RAB7A | Small GTPase | Prenylation target; controls endocytic trafficking |
| FDPSL | Farnesyl diphosphate synthase-like | Plant-specific isoform for sesquiterpene biosynthesis |
| GGPPS | Geranylgeranyl diphosphate synthase | Bifunctional in Toxoplasma; drug target |
How Is farnesyl diphosphate catabolic process Regulated?
Farnesyl diphosphate catabolic process is regulated at multiple levels. Feedback inhibition by downstream sterols controls HMG-CoA reductase activity, thereby affecting FPP availability. In neutrophils, TNF inhibitors modulate a mevalonate metabolite/TRPM2/calcium signaling axis, suggesting that inflammatory signals regulate FPP catabolism. In plants, dedicated FDPS isoforms are transcriptionally regulated to balance growth and defense. In Toxoplasma gondii, the bifunctional FDPS/GGPPS enzyme is inhibited by bisphosphonates, linking drug action to FPP catabolism.
farnesyl diphosphate catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FDPS | Bisphosphonate target in Toxoplasma infection | Knockout in T. gondii; drug sensitivity assays |
| GGPS1 | Oocyte aging and prenylation defects | Knockout in mouse oocytes; prenylation assays |
| TRPM2 | Behçet's disease vasculitis | Knockout in neutrophils; calcium imaging |
| HMGCR | Cholesterol biosynthesis disorders | Point mutation in human cells; statin response |
| RHO | Cancer and cytoskeletal disorders | Overexpression in cancer cell lines; prenylation inhibitors |
FPP Catabolism in Aging and Reproductive Health
Mevalonate metabolites, including FPP, boost aged oocyte quality through prenylation of small GTPases. Disruption of FPP catabolism leads to impaired prenylation and reduced oocyte maturation, highlighting its role in reproductive aging.
FPP Catabolism and Vascular Inflammation
In Behçet's disease, TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils. FPP catabolism influences this axis, and its dysregulation contributes to vasculitis.
FPP Catabolism in Infectious Diseases
Staphylococcus aureus utilizes a redundant isoprenoid biosynthetic pathway that includes FPP catabolism to support metabolic versatility and virulence. In Toxoplasma gondii, the bifunctional FDPS/GGPPS enzyme is a target of bisphosphonates, and its inhibition disrupts FPP catabolism, impairing parasite survival.
FPP Catabolism in Plant Defense
In Zea mays, dedicated farnesyl diphosphate synthases circumvent isoprenoid-derived growth-defense tradeoffs. FPP catabolism is redirected toward sesquiterpene biosynthesis, which plays a role in plant defense. Similarly, in tomato fruit, plastidial engineering with coupled FPP pool reconstitution enhances sesquiterpene biosynthesis.
From farnesyl diphosphate catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FDPS knockout reduce FPP levels and affect cell growth? | CRISPR knockout in HeLa or HEK293 cells |
| Does a point mutation in GGPS1 alter substrate specificity? | Knock-in of mutant GGPS1 in human cells |
| Can overexpression of FDPS increase sesquiterpene production? | Overexpression in tomato fruit or yeast |
| Does tagged FDPS localize to peroxisomes? | Knock-in of fluorescent tag in human cells |
| Does TRPM2 knockout affect neutrophil calcium signaling? | Knockout in primary neutrophils or HL-60 cells |
| Does PGGT1B knockout impair Rho prenylation? | CRISPR knockout in fibroblasts; western blot |
How to Study the farnesyl diphosphate catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | FPP, GGPP, sterol levels | Quantify pathway flux in cells [1,6] |
| 13C isotope tracing | Metabolic flux through mevalonate pathway | Determine catabolic rates |
| Western blot for prenylation | Prenylated protein levels | Assess FTase/GGTase activity |
| CRISPR knockout screening | Gene essentiality and drug sensitivity | Identify regulators of FPP catabolism |
| Fluorescence microscopy | Subcellular localization of enzymes | Study organelle-specific catabolism |
| qRT-PCR | mRNA expression of FDPS, GGPS1 | Evaluate transcriptional regulation |
| Enzyme activity assays | FDPS/GGPPS catalytic activity | Measure kinetic parameters |
| Co-immunoprecipitation | Protein-protein interactions | Identify catabolic complexes |
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics can quantify FPP and its catabolic products, such as GGPP and sterols, in cells and tissues [1,6]. Isotope tracing with 13C-labeled precursors allows flux analysis through the mevalonate pathway.
Prenylation Assays
Prenylation of small GTPases can be assessed by western blotting with anti-farnesyl or anti-geranylgeranyl antibodies, or by metabolic labeling with 3H-mevalonate followed by immunoprecipitation.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate FPP catabolism and sensitivity to statins or bisphosphonates [1,5]. Libraries targeting isoprenoid pathway genes enable focused screens.
Imaging and Subcellular Localization
Fluorescent tagging of FDPS, GGPS1, or prenylated proteins allows live-cell imaging to track their subcellular localization and dynamics. Super-resolution microscopy can resolve prenylation events at membranes.
How CRISPR Can Be Used to Study GO:0045339 farnesyl diphosphate catabolic process
Knockout
CRISPR knockout of FDPS or GGPS1 in human cell lines abolishes FPP catabolism, leading to reduced prenylation and altered cholesterol synthesis [1,6]. Knockout of TRPM2 in neutrophils impairs calcium signaling in response to mevalonate metabolites.
Point Mutation
Point mutations in the catalytic domain of FDPS or GGPS1 can be introduced to study substrate specificity and drug resistance. For example, mutations in GGPS1 that alter GGPP production affect Rab prenylation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into the endogenous FDPS locus allows real-time tracking of enzyme localization and dynamics without overexpression artifacts. Knock-in of disease-associated mutations in HMGCR can model cholesterol disorders.
Overexpression
Overexpression of FDPS or GGPS1 in plant or microbial systems enhances flux toward sesquiterpenes or sterols, demonstrating the potential for metabolic engineering. In mammalian cells, overexpression can rescue knockout phenotypes and validate gene function.
How EDITGENE Supports farnesyl diphosphate catabolic process Research
Researchers studying farnesyl diphosphate catabolic process-related genes often need to determine whether a candidate gene is causally involved in FPP breakdown, prenylation, or related diseases. EDITGENE provides comprehensive CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for farnesyl diphosphate catabolic process research.
Frequently Asked Questions About farnesyl diphosphate catabolic process
What is farnesyl diphosphate catabolic process?
It is the set of biochemical reactions that break down farnesyl diphosphate (FPP), a key isoprenoid intermediate, into downstream products such as geranylgeranyl diphosphate and prenylated proteins [1,6].
What genes are involved in farnesyl diphosphate catabolic process?
Key genes include FDPS, GGPS1, FNTA, FNTB, PGGT1B, RABGGTA, and RABGGTB, which encode enzymes that synthesize or consume FPP [1,2].
What is the GO ID for farnesyl diphosphate catabolic process?
The Gene Ontology ID is GO:0045339.
Why is farnesyl diphosphate catabolism important?
It maintains metabolic balance, prevents toxic accumulation of FPP, and supplies precursors for protein prenylation, which is critical for cell signaling [1,3].
How is farnesyl diphosphate catabolic process regulated?
It is regulated by feedback mechanisms, inflammatory signals, and drugs like statins and bisphosphonates that target the mevalonate pathway [3,6,8].
What diseases are linked to farnesyl diphosphate catabolism?
Dysregulation is associated with oocyte aging, Behçet's disease vasculitis, and infections such as Toxoplasma and Staphylococcus aureus [1,3,5,8].
What experimental models are used to study FPP catabolism?
CRISPR knockout, point mutation, knock-in, and overexpression cell models, as well as metabolomics and prenylation assays [1,5,6].
Can CRISPR be used to study farnesyl diphosphate catabolic process?
Yes, CRISPR knockout of FDPS or GGPS1 abolishes FPP catabolism, and knock-in of tags allows localization studies [1,6].
What are the synonyms for farnesyl diphosphate catabolic process?
Farnesyl diphosphate breakdown, farnesyl diphosphate catabolism, and farnesyl diphosphate degradation.
How does farnesyl diphosphate catabolism affect protein prenylation?
FPP is used as a substrate for farnesyltransferase and geranylgeranyltransferase, which attach prenyl groups to small GTPases, enabling membrane localization and signaling [1,2].
Conclusion
Farnesyl diphosphate catabolic process (GO:0045339) is a fundamental biological process that controls the fate of a central isoprenoid intermediate. Its dysregulation contributes to aging, inflammatory diseases, and infections, making it a compelling target for research and therapeutic development [1,3,5,8]. By leveraging CRISPR-based models and advanced metabolomics, researchers can dissect the molecular players and regulatory networks of FPP catabolism. EDITGENE offers a full suite of services to support these efforts, from knockout cell lines to library screening and bioinformatics.
References
- 1. Liu C et al.. 2025. Mevalonate metabolites boost aged oocyte quality through prenylation of small GTPases.. Nat Aging 5(10):2022-2038 PMID: 40858817
- 2. Tang YJ et al.. 2024. Cyclo-farnesyl Diphosphate-Dependent Prenylation in Fungi.. Org Lett 26(39):8366-8370 PMID: 39310987
- 3. Zhang M et al.. 2024. TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.. Nat Commun 15(1):9261 PMID: 39461948
- 4. Tang HV et al.. 2022. Dedicated farnesyl diphosphate synthases circumvent isoprenoid-derived growth-defense tradeoffs in Zea mays.. Plant J 112(1):207-220 PMID: 35960639
- 5. Burtchett TA et al.. 2025. A redundant isoprenoid biosynthetic pathway supports Staphylococcus aureus metabolic versatility.. mBio 16(8):e0035325 PMID: 40586551
- 6. Krisans SK. 1996. Cell compartmentalization of cholesterol biosynthesis.. Ann N Y Acad Sci 804:142-64 PMID: 8993542
- 7. Chen J et al.. 2023. Plastidial engineering with coupled farnesyl diphosphate pool reconstitution and enhancement for sesquiterpene biosynthesis in tomato fruit.. Metab Eng 77:41-52 PMID: 36893914
- 8. Ling Y et al.. 2007. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.. J Biol Chem 282(42):30804-16 PMID: 17724033
